AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 66(2), 2002, pp. 117-123
Copyright © 2002 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basco, L.
Right arrow Articles by Ringwald, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basco, L.
Right arrow Articles by Ringwald, P
Related Collections
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 66, Issue 2, 117-123
Copyright © 2002 by American Society of Tropical Medicine and Hygiene

Research Articles


Molecular epidemiology of malaria in cameroon. IX. Characteristics of recrudescent and persistent Plasmodium falciparum infections after chloroquine or amodiaquine treatment in children

LK Basco, M Ndounga, A Keundjian, and P Ringwald

In the absence of a firmly established gene responsible for chloroquine and amodiaquine resistance in Plasmodium falciparum, surveillance of resistance to these first-line drugs in Cameroon needs to be performed by in vivo or in vitro tests for drug resistance. These 2 methodological approaches to define drug resistance were shown to be complementary and concordant in a majority of cases at our study sites, but discordant results may be observed in a few cases, probably as a result of acquired immunity and low plasma drug levels. To further examine the nature of recrudescent and persistent parasitemia after treatment with chloroquine or amodiaquine, the clinical response of children aged < 5 years, presumably with insufficient immune response, was assessed, and the in vitro response of the corresponding isolates was determined if treatment or parasitological failure occurred. Genotyping of pretreatment and posttreatment isolates was performed by polymerase chain reaction to distinguish between recrudescence and reinfection. Plasma drug levels were measured at the time of therapeutic failure by high-performance liquid chromatography. All cases of therapeutic or parasitological failure observed on or before Day 14 were due to the persistence or recrudescence of the original parasite populations present before treatment, with or without selection and appearance of new populations. Most parasites were characterized by elevated 50% inhibitory concentrations for chloroquine and amodiaquine at the time of clinical or parasitological failure. In some children, recrudescence was explained by the absence of drug in the plasma. The simultaneous analysis of clinical and in vitro responses, plasma drug level measurement, and genotyping may yield results that may explain the reasons for therapeutic failure, help establish the threshold level for in vitro resistance, and provide a set of more accurate tools to describe the epidemiology of drug-resistant P. falciparum while awaiting for the identification of the chloroquine and amodiaquine resistance gene or genes.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
R. Tahar and L. K. Basco
Molecular Epidemiology of Malaria in Cameroon. XXV. In Vitro Activity of Fosmidomycin and its Derivatives against Fresh Clinical Isolates of Plasmodium falciparum and Sequence Analysis of 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase
Am J Trop Med Hyg, August 1, 2007; 77(2): 214 - 220.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
L. K. BASCO and P. RINGWALD
MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XXIV. TRENDS OF IN VITRO ANTIMALARIAL DRUG RESPONSES IN YAOUNDE, CAMEROON
Am J Trop Med Hyg, January 1, 2007; 76(1): 20 - 26.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
L. K. BASCO
MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XXIII. EXPERIMENTAL STUDIES ON SERUM SUBSTITUTES AND ALTERNATIVE CULTURE MEDIA FOR IN VITRO DRUG SENSITIVITY ASSAYS USING CLINICAL ISOLATES OF PLASMODIUM FALCIPARUM
Am J Trop Med Hyg, November 1, 2006; 75(5): 777 - 782.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
L. K. BASCO, V. F. NGANE, M. NDOUNGA, A. SAME-EKOBO, J.-C. YOUMBA, R. T. O. ABODO, and G. SOULA
MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XXI. BASELINE THERAPEUTIC EFFICACY OF CHLOROQUINE, AMODIAQUINE, AND SULFADOXINE-PYRIMETHAMINE MONOTHERAPIES IN CHILDREN BEFORE NATIONAL DRUG POLICY CHANGE.
Am J Trop Med Hyg, September 1, 2006; 75(3): 388 - 395.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
M. LEMNGE, M. ALIFRANGIS, M. Y. KAFUYE, M. D. SEGEJA, S. GESASE, D. MINJA, J. J. MASSAGA, A. M. RONN, and I. C. BYGBJERG
High reinfection rate and treatment failures in children treated with amodiaquine for falciparum malaria in muheza villages, northeastern Tanzania.
Am J Trop Med Hyg, August 1, 2006; 75(2): 188 - 193.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. AUBOUY, J. MAYOMBO, A. KEUNDJIAN, M. BAKARY, J. LE BRAS, and P. DELORON
SHORT REPORT: LACK OF PREDICTION OF AMODIAQUINE EFFICACY IN TREATING PLASMODIUM FALCIPARUM MALARIA BY IN VITRO TESTS
Am J Trop Med Hyg, September 1, 2004; 71(3): 294 - 296.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
L. K. BASCO
MOLECULAR EPIDEMIOLOGY OF MALARIA IN CAMEROON. XX. EXPERIMENTAL STUDIES ON VARIOUS FACTORS OF IN VITRO DRUG SENSITIVITY ASSAYS USING FRESH ISOLATES OF PLASMODIUM FALCIPARUM
Am J Trop Med Hyg, May 1, 2004; 70(5): 474 - 480.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society of Tropical Medicine and Hygiene.